Tina-Quant Cystatin C, Calibrator F.A.S. Cystatin C and Cystatin C Andcystatin C Control Set
Test, Cystatin C. 510(k) K080811, from Roche Diagnostics Corp. (Indianapolis, IN). Product code NDY, class 2.
As of Nov 20, 2026, K080811 is an FDA 510(k) held by Roche Diagnostics Corp., substantially equivalent on Jun 20, 2008 after 88 days, with no recalls tied to it in FDA's recall database.
- Review time: 88 days
- Recalls: 0
- Cited as a predicate by: 1 device
Reagent: Immunoturbidimetric assay for the quantitative in vitro determination of cystatin C in human serum and lithium-heparin plasma on Roche automated clinical chemistry analyzers. Cystatin C measurements are used as an aid in the diagnosis and treatment of renal diseases.
- Cystatin C Immunoparticles, Control Set, CalibratorK041627 · Dako A/S · Sep 3, 2004
- Cobas C Tina-Quant Cystatin C GEN.2 Assay, C.F.A.S. Cystatin C Calibrator, Cystatin C GEN.2 Control SetK141143 · Roche Diagnostics · Jul 17, 2014
- Cystatin CK242585 · SENTINEL CH. SpA · May 16, 2025
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 24, 2008
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files